CAJ | 학술논문

近年来随着肿瘤分子生物学技术的发展,分子靶向药物治疗已成为众多学者关注的热点领域,对乳腺癌的治疗策略产生了重大影响.其中,人表皮生长因子受体-2(Her-2)已证实为一个有效的分子靶向治疗的靶标,针对乳腺癌Her-2的分子靶向治疗成为近来继化疗和内分泌治疗后又一重要的治疗手段.
근년래수착종류분자생물학기술적발전,분자파향약물치료이성위음다학자관주적열점영역,대유선암적치료책략산생료중대영향.기중,인표피생장인자수체-2(Her-2)이증실위일개유효적분자파향치료적파표,침대유선암Her-2적분자파향치료성위근래계화료화내분비치료후우일중요적치료수단.
In recent years,with the development of tumor molecular biology technology,molecular targeted therapy has become a study hotspot,which plays a significant role on breast cancer treatment strategy.Among them,the human epidermal growth factor receptor-2 (Her-2) has been proven as an effective molecular target.So molecular targeted therapy of breast cancer become another important treatment except chemotherapy and endocrine therapy.